155 related articles for article (PubMed ID: 20186105)
1. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas.
Zhang J; Zheng Y; Wang Y; Tong H
J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
[TBL] [Abstract][Full Text] [Related]
4. [Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study].
Eggert A; Grotzer MA; Zhao H; Brodeur GM; Evans AE
Klin Padiatr; 2001; 213(4):191-6. PubMed ID: 11528553
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of TRK neurotrophin receptors in advanced neuroblastomas in Singapore--a pilot study.
Fung W; Hasan MY; Loh AH; Chua JH; Yong MH; Knight L; Hwang WS; Chan MY; Seow WT; Jacobsen AS; Chui CH
Pediatr Hematol Oncol; 2011 Oct; 28(7):571-8. PubMed ID: 21728718
[TBL] [Abstract][Full Text] [Related]
6. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
7. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
8. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute.
Hishiki T; Saito T; Terui K; Sato Y; Takenouchi A; Yahata E; Ono S; Nakagawara A; Kamijo T; Nakamura Y; Matsunaga T; Yoshida H
J Pediatr Surg; 2010 Dec; 45(12):2293-8. PubMed ID: 21129533
[TBL] [Abstract][Full Text] [Related]
9. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
[TBL] [Abstract][Full Text] [Related]
10. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
Takahashi M; Ozaki T; Todo S; Nakagawara A
Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
[TBL] [Abstract][Full Text] [Related]
12. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
Tang XX; Evans AE; Zhao H; Cnaan A; London W; Cohn SL; Brodeur GM; Ikegaki N
Clin Cancer Res; 1999 Jun; 5(6):1491-6. PubMed ID: 10389937
[TBL] [Abstract][Full Text] [Related]
13. Cathepsins B and L in peripheral blood mononuclear cells of pediatric acute myeloid leukemia: potential poor prognostic markers.
Jain M; Bakhshi S; Shukla AA; Chauhan SS
Ann Hematol; 2010 Dec; 89(12):1223-32. PubMed ID: 20567828
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
[TBL] [Abstract][Full Text] [Related]
16. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
de Souza DR; Sanabani SS; de Souza AC; Filho Odone V; Epelman S; Bendit I
Pediatr Blood Cancer; 2011 May; 56(5):749-56. PubMed ID: 21154590
[TBL] [Abstract][Full Text] [Related]
19. Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma.
Shimada A; Hirato J; Kuroiwa M; Kikuchi A; Hanada R; Wakai K; Hayashi Y
Pediatr Blood Cancer; 2008 Feb; 50(2):213-7. PubMed ID: 17941064
[TBL] [Abstract][Full Text] [Related]
20. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
